Table 2

Comparative sensitivity and specificity of three commercial anti-CCP2 antibody kits and RF

CCP2RF (BMD®)
Diastat®Inova®Euro-Diagnostica®
CCP, cyclic citrullinated peptide; RA, rheumatoid arthritis; RF, rheumatoid factor.
RA (n = 45)37 (82%)38 (85%)38 (85%)42 (94%)
Control (n = 22)2 (9.1%)1 (4.5%)2 (9.1%)12 (53%)